<qa>  What is the concomitant use of potent inhibitors or inducers of the- concomitant use of potent inhibitors or inducers of the cytochrome P450 CYP enzymes 3A and 2C19 within 1 week prior to the first dose of bortezomib and during Cycle 1 see annex VII list of representative drugs. 